BioLineRx Ltd Tangible Net Worth Ratio
BioLineRx Ltd tangible net worth ratio. BioLineRx Ltd (BLRX) has a Tangible Net Worth Ratio of 1.8% as of June 2026. This metric is calculated by deducting intangible assets ($16.33 Million) from net assets ($16.62 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check BLRX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of BioLineRx Ltd (2008–2025)
Tangible net worth ratio of BioLineRx Ltd from 2008 to 2025. This chart shows how BioLineRx Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 1.8%, reflecting net assets of $16.62 Million with intangible assets of $16.33 Million USD. See BioLineRx Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
BioLineRx Ltd Tangible Net Worth Ratio by Year (2008–2025)
BioLineRx Ltd tangible net worth ratio by year from 2008 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see BLRX market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.9% | $23.34 Million | $16.37 Million | $40.90 Million | ▲ +7.5 pp |
| 2024 | 22.4% | $13.46 Million | $10.45 Million | $38.91 Million | ▲ +34.7 pp |
| 2023 | -12.3% | $13.22 Million | $14.85 Million | $63.92 Million | ▼ -69.3 pp |
| 2022 | 57.0% | $50.84 Million | $21.89 Million | $76.38 Million | ▼ -11.2 pp |
| 2021 | 68.1% | $68.09 Million | $21.70 Million | $81.39 Million | ▲ +66.7 pp |
| 2020 | 1.4% | $22.03 Million | $21.71 Million | $47.29 Million | ▼ -33.0 pp |
| 2019 | 34.4% | $33.38 Million | $21.89 Million | $53.57 Million | ▼ -12.4 pp |
| 2018 | 46.8% | $41.32 Million | $21.97 Million | $56.23 Million | ▼ -39.9 pp |
| 2017 | 86.7% | $52.88 Million | $7.02 Million | $60.97 Million | ▼ -12.8 pp |
| 2016 | 99.5% | $35.03 Million | $181.00K | $38.94 Million | ▼ -0.2 pp |
| 2015 | 99.7% | $47.61 Million | $152.00K | $51.30 Million | ▲ +0.1 pp |
| 2014 | 99.6% | $31.77 Million | $117.36K | $36.17 Million | ▲ +1.8 pp |
| 2013 | 97.8% | $11.68 Million | $252.12K | $19.95 Million | ▼ -0.3 pp |
| 2012 | 98.1% | $14.97 Million | $284.53K | $24.31 Million | ▼ -0.6 pp |
| 2011 | 98.7% | $22.53 Million | $300.58K | $29.34 Million | ▼ -0.3 pp |
| 2010 | 99.0% | $37.26 Million | $381.76K | $43.66 Million | ▲ +1.6 pp |
| 2009 | 97.4% | $31.13 Million | $803.06K | $42.02 Million | ▲ +1.5 pp |
| 2008 | 95.9% | $20.75 Million | $848.56K | $30.64 Million | — |